Ignite Creation Date:
2025-12-24 @ 12:02 PM
Ignite Modification Date:
2025-12-27 @ 9:12 PM
Study NCT ID:
NCT00116961
Status:
COMPLETED
Last Update Posted:
2012-02-07
First Post:
2005-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UMCC 2004.047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Andrzej J. Jakubowiak, MD, PhD
Old Organization:
University of Michigan Comprehensive Cancer Center